Why the study?
The reasons why respiratory RNA viruses differ in disease severity and reinfection capability, and whether they share unique or common immune evasion features, remain incompletely understood.
Key points are not available for this paper at this time.
Design
Review
May inform host shutoff-targeted antivirals; leaves open clinical validation in respiratory infections.
To replicate and spread efficiently, RNA viruses must inhibit the host immune signaling pathways and/or induce host shutoff and thereby evade host immunity. However, not all RNA viruses have the same consequences in terms of disease severity and ability to cause reinfections. What are the reasons for such differences? Are there any unique or common features of viral immune evasion? Answering these questions is imperative to elucidate the role of the balance between damaging pro-inflammatory and protective antiviral responses and to inform development of new therapeutic strategies. In this review, we provide a comparative overview of the knowledge regarding the innate immune evasion and general host shutoff strategies used by respiratory RNA viruses to enable their persistent spread in humans. We demonstrate that these viruses encode multiple and often redundant mechanisms of innate immune suppression, with potent general host shutoff being characteristic of viruses with wider host range and greater ability to cause reinfections. Accordingly, we argue that increased research effort in characterizing host shutoff mechanisms of different viruses and their contribution to virus fitness is needed to determine if targeting host shutoff represents a viable avenue for developing new antiviral therapies.
No takes yet. Share an insight, caveat, or question.
Bougon et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: